CMV reactivation after allogeneic HCT is associated with a reduced risk of relapse in acute lymphoblastic leukemia

  • Yu Akahoshi
  • , Hideki Nakasone
  • , Katsuto Takenaka
  • , Satoshi Yamasaki
  • , Momoko Nakamura
  • , Noriko Doki
  • , Masatsugu Tanaka
  • , Yukiyasu Ozawa
  • , Naoyuki Uchida
  • , Takahide Ara
  • , Hirohisa Nakamae
  • , Shuichi Ota
  • , Makoto Onizuka
  • , Shingo Yano
  • , Junji Tanaka
  • , Takahiro Fukuda
  • , Yoshinobu Kanda
  • , Yoshiko Atsuta
  • , Shinichi Kako
  • , Masamitsu Yanada
    • Yasuyuki Arai

Research output: Contribution to journal › Article › peer-review

17 Scopus citations

Fingerprint

Dive into the research topics of 'CMV reactivation after allogeneic HCT is associated with a reduced risk of relapse in acute lymphoblastic leukemia'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Immunology and Microbiology